Physician
Forward Pathology Solutions LLC
Forward Pathology Solutions LLC was paid $2.75M by Medicaid between Oct 2019 and Nov 2024, across 138 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 45% of everything it billed.
33Billing provider infoFORWARD PATHOLOGY SOLUTIONS LLC
RICHMOND, VA 23229
RICHMOND, VA 23229
33aNPI1982266391assigned 07/05/2019
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.75M
24GClaims1,641,326
24DCodes billed138
24AFirst – last monthOct 2019 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Virginia
Rank by total paid#3 of 63
Median peer was paid$6K
This provider vs. median442×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 56,679 | $69K | |
| 2020 | 190,415 | $384K | |
| 2021 | 345,510 | $763K | |
| 2022 | 360,955 | $640K | |
| 2023 | 369,162 | $550K | |
| 2024incomplete | 318,605 | $341K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 45% | 27,790 | 25,465 | $1.23M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12% | 16,114 | 14,469 | $343K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 12% | 53,419 | 42,759 | $321K |
| 88307 | 7.9% | 3,124 | 2,946 | $216K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.5% | 26,749 | 24,943 | $152K |
| 85027 | 2.7% | 337,183 | 136,035 | $75K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 5,336 | 4,887 | $61K |
| 80053 | Comprehensive metabolic panel | 1.8% | 163,648 | 91,133 | $50K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 156,781 | 63,556 | $32K |
| 83735 | 1.1% | 109,967 | 43,675 | $30K | |
| 88304 | 1.0% | 3,378 | 3,130 | $28K | |
| 88342 | <1% | 1,277 | 1,112 | $20K |
126 more codes
| 82803 | <1% | 24,697 | $18K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 31,174 | $17K |
| 84484 | <1% | 39,906 | $15K | |
| 87040 | <1% | 26,373 | $15K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 40,871 | $13K |
| 84100 | <1% | 57,947 | $11K | |
| 83605 | <1% | 29,028 | $10K | |
| 80202 | <1% | 9,243 | $6K | |
| 80074 | <1% | 1,928 | $4K | |
| 88341 | <1% | 96 | $4K | |
| 83880 | <1% | 13,774 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 17,566 | $3K |
| 81001 | <1% | 37,290 | $3K | |
| 82728 | <1% | 5,891 | $3K | |
| 87070 | <1% | 11,151 | $2K | |
| 84703 | <1% | 12,470 | $2K | |
| 82140 | <1% | 3,727 | $2K | |
| 85610 | <1% | 21,908 | $2K | |
| 80076 | <1% | 11,790 | $2K | |
| 86901 | <1% | 17,884 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,423 | $2K |
| 85520 | <1% | 7,333 | $2K | |
| 82330 | <1% | 5,054 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,507 | $2K |
| 85060 | <1% | 157 | $2K | |
| 87205 | <1% | 11,646 | $2K | |
| 80061 | Lipid panel | <1% | 10,623 | $2K |
| 82565 | <1% | 7,221 | $2K | |
| 85018 | <1% | 25,370 | $1K | |
| 81003 | <1% | 19,548 | $1K | |
| 85390 | <1% | 90 | $1K | |
| 83550 | <1% | 5,076 | $1K | |
| 81025 | <1% | 26,015 | $1K | |
| 86140 | <1% | 8,616 | $1K | |
| 87077 | <1% | 6,096 | $1K | |
| 86850 | <1% | 23,329 | $1K | |
| 85379 | <1% | 7,990 | $1K | |
| 88312 | <1% | 54 | $1K | |
| 88108 | <1% | 105 | $1K | |
| 80069 | <1% | 5,118 | $1K | |
| 84132 | <1% | 6,513 | $1K | |
| 83540 | <1% | 5,256 | $1K | |
| 85730 | <1% | 7,750 | $1K | |
| 85014 | <1% | 18,312 | $1K | |
| 82607 | <1% | 2,532 | $885.04 | |
| 83690 | <1% | 8,310 | $868.22 | |
| 82248 | <1% | 7,510 | $846.62 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 180 | $833.56 |
| 86900 | <1% | 21,563 | $832.12 | |
| 82947 | <1% | 5,558 | $636.40 | |
| 88302 | <1% | 85 | $594.84 | |
| 82746 | <1% | 1,490 | $592.02 | |
| 80164 | <1% | 1,144 | $586.76 | |
| 82247 | <1% | 2,732 | $578.40 | |
| 85045 | <1% | 3,262 | $547.23 | |
| 87400 | <1% | 1,454 | $533.61 | |
| 84439 | <1% | 2,216 | $518.76 | |
| 84295 | <1% | 3,683 | $516.57 | |
| 85049 | <1% | 6,413 | $510.36 | |
| 88112 | <1% | 26 | $508.57 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,168 | $504.89 |
| 85007 | <1% | 4,299 | $468.86 | |
| 86920 | <1% | 327 | $406.28 | |
| 87088 | <1% | 1,300 | $360.65 | |
| 86885 | <1% | 1,368 | $331.76 | |
| 84550 | <1% | 2,402 | $323.88 | |
| 88720 | <1% | 2,263 | $259.34 | |
| 86141 | <1% | 451 | $252.84 | |
| 84520 | <1% | 1,360 | $225.32 | |
| 87899 | <1% | 406 | $221.76 | |
| 88311 | <1% | 29 | $219.98 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 766 | $192.00 |
| 87186 | <1% | 1,876 | $191.99 | |
| 84702 | <1% | 643 | $187.54 | |
| 84112 | <1% | 289 | $175.30 | |
| 87340 | <1% | 305 | $144.62 | |
| 86880 | <1% | 2,109 | $143.55 | |
| 87150 | <1% | 126 | $140.36 | |
| 87486 | <1% | 153 | $140.36 | |
| 82274 | <1% | 57 | $127.36 | |
| 87075 | <1% | 328 | $126.36 | |
| 85652 | <1% | 1,059 | $108.30 | |
| 83615 | <1% | 674 | $102.34 | |
| 82550 | <1% | 1,553 | $97.58 | |
| 89051 | <1% | 609 | $95.20 | |
| 82077 | <1% | 1,636 | $91.14 | |
| 87493 | <1% | 93 | $88.69 | |
| 87147 | <1% | 533 | $84.36 | |
| 82010 | <1% | 1,022 | $84.00 | |
| 87449 | <1% | 485 | $78.54 | |
| 82570 | <1% | 722 | $62.16 | |
| 87210 | <1% | 115 | $59.64 | |
| 82375 | <1% | 154 | $57.27 | |
| 80177 | <1% | 21 | $52.04 | |
| 86922 | <1% | 34 | $51.60 | |
| 80305 | <1% | 149 | $50.40 | |
| 85651 | <1% | 309 | $41.85 | |
| 80178 | <1% | 92 | $39.20 | |
| 87807 | <1% | 784 | $26.20 | |
| 82272 | <1% | 376 | $18.95 | |
| 84156 | <1% | 289 | $18.35 | |
| 89055 | <1% | 26 | $17.08 | |
| 80051 | <1% | 923 | $14.80 | |
| 85048 | <1% | 145 | $14.17 | |
| 82435 | <1% | 291 | $13.51 | |
| 86870 | <1% | 140 | $12.60 | |
| 86703 | <1% | 1,167 | $11.55 | |
| 86738 | <1% | 191 | $10.04 | |
| 85384 | <1% | 69 | $4.84 | |
| 84300 | <1% | 31 | $4.26 | |
| 86756 | <1% | 79 | $2.84 | |
| 82150 | <1% | 14 | $2.80 | |
| 87045 | <1% | 42 | $2.42 | |
| 86762 | <1% | 14 | $1.72 | |
| 85347 | <1% | 101 | $1.55 | |
| 87046 | <1% | 19 | $1.01 | |
| 87641 | 0% | 91 | $0.00 | |
| 84145 | 0% | 19 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 46 | $0.00 |
| 82800 | 0% | 17 | $0.00 | |
| 80143 | 0% | 13 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 58 | $0.00 |
| 84157 | 0% | 27 | $0.00 | |
| 86780 | 0% | 200 | $0.00 | |
| 83935 | 0% | 14 | $0.00 | |
| 87581 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUCH, SANDRA (PROJECT MANAGER)
| Provider | Location | Paid |
|---|---|---|
| NTX Pathology Program, PLLC | Dallas, TX | $24K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.